1. Show article details.

    Maryland Cove Point LNG export plant to start work next week -analysts

    Reuters – 12:15 PM ET 09/15/2021

    Berkshire Hathaway Energy's Cove Point liquefied natural gas export plant in Maryland will shut for about three weeks of maintenance starting around Sept. 20, according to pipeline data and analysts.

  2. Show article details.

    Bolsonaro emerges as risk factor for Brazil IPO pipeline

    Reuters – 7:19 AM ET 09/14/2021

    Competition, the pandemic and sectoral demand are common challenges facing companies planning initial public offerings, but Brazilian companies have started to flag a new risk: political upheaval from far-right President Jair Bolsonaro.

  3. Show article details.

    Buffett-backed Nubank to seek IPO valuation of over $55 bln -sources

    Reuters – 5:26 PM ET 08/25/2021

    Brazil's Nubank is seeking a valuation in its planned U.S. initial public offering that would push the eight-year-old fintech past the $55.4 billion value of the country's top traditional lender, two sources familiar with the matter said. In a recent funding round led by Warren Buffett's Berkshire Hathaway Inc (BRK/A), Nubank was valued at $30 billion.

  4. Show article details.

    Deals of the day-Mergers and acquisitions

    Reuters – 6:00 AM ET 08/17/2021

    The following bids, mergers, acquisitions. ** BHP Group has agreed to sell its petroleum business to Woodside Petroleum in a merger to create a top 10 independent oil and gas company worth A$38.5 billion with growth assets in Australia and America.

  5. Show article details.

    Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

    Reuters – 5:41 PM ET 08/16/2021

    - Warren Buffett's Berkshire Hathaway Inc (BRK/A) said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co (MRK) spinoff, Organon & Co. In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc (BIIB) and reduced investments in Abbvie Inc (ABBV), Bristol-Myers Squibb Co (BMY) and Merck.

  6. Show article details.

    Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

    Reuters – 5:37 PM ET 08/16/2021

    Warren Buffett's Berkshire Hathaway Inc (BRK/A) said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co (MRK) spinoff, Organon & Co. In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc (BIIB) and reduced investments in Abbvie Inc (ABBV), Bristol-Myers Squibb Co (BMY) and Merck.

  7. Show article details.

    BRIEF-Berkshire Hathaway Cuts Share Stake In Abbvie, Bristol-Myers, Merck and GM

    Reuters – 5:02 PM ET 08/16/2021

    * BERKSHIRE HATHAWAY CUTS SHARE STAKE IN ABBVIE INC BY 10.2% TO 20.5 MILLION SHARES. * BERKSHIRE HATHAWAY CUTS SHARE STAKE IN BRISTOL-MYERS SQUIBB CO BY 15.3% TO 26.3 MILLION SHARES. * BERKSHIRE HATHAWAY CUTS SHARE STAKE IN GENERAL MOTORS CO BY 10.4% TO 60 MILLION SHARES. * BERKSHIRE HATHAWAY CUTS SHARE STAKE IN MERCK & CO INC BY 48.8% TO 9.2 MILLION SHARES.

  8. Show article details.

    BRIEF-Berkshire Hathaway Takes Share Stake In Organon & Co

    Reuters – 4:53 PM ET 08/16/2021

    Berkshire Hathaway Inc (BRK/A): * BERKSHIRE HATHAWAY TAKES SHARE STAKE IN ORGANON & CO. * BERKSHIRE HATHAWAY TAKES SHARE STAKE IN ORGANON & CO OF 1.6 MILLION SHARES - SEC FILING. * BERKSHIRE HATHAWAY (BRK/A) - CHANGE IN HOLDINGS ARE AS OF JUNE 30, 2021 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF MARCH 31, 2021 Source for the quarter ended June 30, 2021: https://bit.ly/37P04vW.

  9. Show article details.

    Buffett's Berkshire sheds Axalta, Biogen; buys Organon

    Reuters – 4:29 PM ET 08/16/2021

    Warren Buffett's Berkshire Hathaway Inc (BRK/A) said on Monday it has shed its holdings of drugmaker Biogen Inc (BIIB) and paint maker Axalta Coating Systems Ltd (AXTA), while taking a new stake in another pharmaceutical company, Organon & Co. The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.

  10. Show article details.

    Tencent, SoftBank-led funding pushes Argentina's Uala to $2.45 bln valuation

    Reuters – 1:54 PM ET 08/13/2021

    China's online giant, Tencent Holdings Ltd, and SoftBank Group Corp's Latin America-focused fund led an investment round for Argentine firm Uala which took its valuation to $2.45 billion, the fintech company said on Friday.

  11. Show article details.

    BRIEF-Lightning eMotors And Forest River Inc Reach Multi-year Agreement For Up To $850 Mln In Zero-Emission Bus Technology Plus Charging Products And Services

    Reuters – 7:45 AM ET 08/10/2021

    Lightning eMotors Inc (ZEV): * LIGHTNING EMOTORS AND FOREST RIVER INC. REACH MULTIYEAR AGREEMENT FOR UP TO $850 MILLION IN ZERO-EMISSION BUS TECHNOLOGY PLUS CHARGING PRODUCTS AND SERVICES. * Lightning eMotors Inc (ZEV) - CO, FOREST RIVER ENTERED INTO A STRATEGIC PARTNERSHIP AGREEMENT TO DEPLOY UP TO 7,500 ZERO-EMISSION SHUTTLE BUSES Source text for Eikon: Further company coverage:

  12. Show article details.

    Buffett-backed Nubank hires investment banks to lead IPO - source

    Reuters – 6:12 PM ET 08/09/2021

    - Nubank, the Brazilian digital bank backed by Warren Buffett's Berkshire Hathaway (BRK/A), has hired Morgan Stanley (MS), Goldman Sachs (GS) and Citigroup (C) to help lead its U.S. initial public offering, a source familiar with the matter said on Monday. Reuters reported in June that Nubank had invited investment banks to pitch for roles in the upcoming IPO, which could value the company at more than $40 billion.

  13. Show article details.

    Buffett-backed Nubank hires investment banks to lead IPO - source

    Reuters – 5:57 PM ET 08/09/2021

    Nubank, the Brazilian digital bank backed by Warren Buffett's Berkshire Hathaway (BRK/A), has hired Morgan Stanley (MS), Goldman Sachs (GS) and Citigroup (C) to help lead its U.S. initial public offering, a source familiar with the matter said on Monday. Reuters reported in June that Nubank had invited investment banks to pitch for roles in the upcoming IPO, which could value the company at more than $40 billion.

  14. Show article details.

    BRIEF-Berkshire Hathaway Says It Had About $144.1 Bln Of Cash And Equivalents As Of June 30

    Reuters – 9:47 AM ET 08/07/2021

    Berkshire Hathaway (BRK/A): * BERKSHIRE OWNED $124.3 BILLION APPLE SHARES AS OF JUNE 30, COMPARED WITH REPORTED $110.9 BILLION AS OF MARCH 31. * BERKSHIRE OWNED $42.6 BLN BANK OF AMERICA SHARES AS OF JUNE 30, COMPARED WITH REPORTED $40 BILLION AS OF MARCH 31. * IT HAD ABOUT $144.1 BILLION OF CASH AND EQUIVALENTS AS OF JUNE 30.

  15. Show article details.

    Warren Buffett's Berkshire Hathaway recovers from coronavirus slowdown

    Reuters – 8:56 AM ET 08/07/2021

    Warren Buffett's Berkshire Hathaway Inc (BRK/A) on Saturday said many of its businesses are enjoying strong recoveries from the early depths of the coronavirus pandemic, fueling rebounds in profits and revenue.

  16. Show article details.

    BRIEF-Berkshire Hathaway Reprts Q2 Operating Earnings Of $6.69 Bln Versus $5.51 Bln

    Reuters – 8:18 AM ET 08/07/2021

    Berkshire Hathaway Inc (BRK/A): * Q2 NET EARNINGS ATTRIBUTABLE TO BERKSHIRE SHAREHOLDERS $28.09 BILLION VERSUS YEAR-EARLIER $26.3 BILLION GAIN. * Q2 OPERATING EARNINGS $6.69 BILLION VERSUS YEAR-EARLIER $5.51 BILLION. * Q2 NET EARNINGS PER AVERAGE EQUIVALENT CLASS A SHARE $18,488. * Q2 NET EARNINGS FROM INVESTMENTS AND DERIVATIVES $21.41 BILLION VERSUS YEAR-EARLIER $31.65 BILLION.

  17. Show article details.

    Warren Buffett's Berkshire Hathaway recovers from coronavirus slowdown

    Reuters – 8:16 AM ET 08/07/2021

    -Warren Buffett's Berkshire Hathaway Inc (BRK/A) on Saturday said many of its businesses are enjoying strong recoveries from the early depths of the coronavirus pandemic, fueling rebounds in profits and revenue.

  18. Show article details.

    Berkshire Hathaway operating profit rises 21%

    Reuters – 8:09 AM ET 08/07/2021

    Berkshire Hathaway Inc (BRK/A) on Saturday reported improved quarterly operating results, as the conglomerate controlled by billionaire Warren Buffett showed signs of recovery from the depths of the coronavirus pandemic. Second-quarter operating profit rose 21% to $6.69 billion from $5.51 billion a year earlier.

  19. Show article details.

    Berkshire Hathaway Inc. News Release

    Business Wire – 8:00 AM ET 08/07/2021

    Berkshire Hathaway Inc. (BRK/A): Berkshire’s operating results for the second quarter and first six months of 2021 and 2020 are summarized in the following paragraphs. Earnings of Berkshire Hathaway Inc. (BRK/A) and its consolidated subsidiaries for the second quarter and first six months of 2021 and 2020 are summarized below.

  20. Show article details.

    BRIEF-Berkshire Hathaway stake in DaVita rises to 34.4%, share count unchanged

    Reuters – 4:34 PM ET 08/04/2021

    Berkshire hathaway reports 34.4% stake in davita on aug 3, up from 33% on feb 12, resulting from davita repurchasing its own shares; share count is unchanged -- sec filing.

Page:

Today's and Upcoming Events

  • Nov
    05

    BRK/B to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

  • Aug
    07

    BRK/B announced Q2 earnings.

Data provided by Thomson Reuters © 2021

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.